NCT01938443 A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01934894 Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases Status TERMINATED Phase PHASE2
NCT01934231 Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis Status COMPLETED Phase PHASE3
NCT01934205 To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 Status COMPLETED Phase PHASE1
NCT01934192 Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study Status TERMINATED Phase PHASE2
NCT01934153 Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01934127 Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age Status COMPLETED Phase PHASE1
NCT01934101 Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers Status TERMINATED Phase PHASE1
NCT01929863 Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin Status COMPLETED Phase PHASE2
NCT01929330 Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01929317 A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients. Status TERMINATED Phase PHASE3
NCT01929291 Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea Status COMPLETED Phase N/A
NCT01929278 W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01928940 Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) Status COMPLETED Phase PHASE2
NCT01924858 A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier. Status TERMINATED Phase PHASE1
NCT01920594 Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair Status COMPLETED Phase PHASE2
NCT01920568 A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors Status COMPLETED Phase PHASE3
NCT01920464 Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians Status COMPLETED Phase N/A